Cargando…

Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma

PURPOSE: Complex crosstalk between tumor cells and platelets is closely related to the development, relapse, and drug resistance of hepatocellular carcinoma (HCC). Therefore, an intensive analysis of the relationship between platelet-related genes and the effectiveness of immunotherapy is necessary...

Descripción completa

Detalles Bibliográficos
Autor principal:	Zhang, Genhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126232/ https://www.ncbi.nlm.nih.gov/pubmed/35615530 http://dx.doi.org/10.2147/JHC.S363200

Ejemplares similares

Endoplasmic Reticulum Stress-Related Signature for Predicting Prognosis and Immune Features in Hepatocellular Carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment
por: Zhang, Genhao
Publicado: (2022)

A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2021)

A Novel Five-Gene Signature for Prognosis Prediction in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2021)

Prognostic Lysosome-Related Biomarkers for Predicting Drug Candidates in Hepatocellular Carcinoma: An Insilco Analysis
por: Xu, Junxiu, et al.
Publicado: (2023)

Prediction of Prognosis in Patients with Hepatocellular Carcinoma Based on Molecular Subtypes of Immune Genes
por: Du, Suming, et al.
Publicado: (2022)

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2022)

Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinoma
por: Lin, Hong-Sheng, et al.
Publicado: (2023)

Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma
por: Chen, Ji, et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
por: Yu, Xue, et al.
Publicado: (2022)

HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma
por: He, Hui, et al.
Publicado: (2020)

A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
por: Liu, Chang, et al.
Publicado: (2022)

Prognostic clinical phenotypes associated with tumor stemness in the immune microenvironment of T-cell exhaustion for hepatocellular carcinoma
por: Zhang, Genhao
Publicado: (2023)

Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Prognostic Significance of Pregnancy Zone Protein and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
por: Su, Lisa, et al.
Publicado: (2020)

Identification and Validation of Two Heterogeneous Molecular Subtypes and a Prognosis Predictive Model for Hepatocellular Carcinoma Based on Pyroptosis
por: Lai, Minshan, et al.
Publicado: (2022)

Evaluation and prediction of hepatocellular carcinoma prognosis based on molecular classification
por: Ke, Kun, et al.
Publicado: (2018)

Molecular subtypes based on Wnt-signaling gene expression predict prognosis and tumor microenvironment in hepatocellular carcinoma
por: Xu, Weifeng, et al.
Publicado: (2022)

A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Predictive Value of Platelet-Related Measures in Patients with Hepatocellular Carcinoma
por: Fan, Zhijia, et al.
Publicado: (2022)

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma
por: Lu, Qingsong, et al.
Publicado: (2023)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

Necroptosis-related signatures identify two distinct hepatocellular carcinoma subtypes: Implications for predicting drug sensitivity and prognosis
por: Tang, Hui, et al.
Publicado: (2023)

Identification and Validation of Ferroptosis-Related Subtypes and a Predictive Signature in Hepatocellular Carcinoma
por: Zheng, Chunlan, et al.
Publicado: (2023)

Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2023)

Identification of copper metabolism and cuproptosis-related subtypes for predicting prognosis tumor microenvironment and drug candidates in hepatocellular carcinoma
por: Liu, Xianglong, et al.
Publicado: (2022)

Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma
por: Hu, Dongzhi, et al.
Publicado: (2023)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness
por: Tu, Sheng, et al.
Publicado: (2023)

Classification molecular subtypes of hepatocellular carcinoma based on PRMT-related genes
por: Liu, Liwen, et al.
Publicado: (2023)

Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization
por: Zhu, Gui-Qi, et al.
Publicado: (2018)

Corona enhancement combined with microvascular invasion for prognosis prediction of macrotrabecular-massive hepatocellular carcinoma subtype
por: Yang, Lili, et al.
Publicado: (2023)

Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma
por: Shan, Yuying, et al.
Publicado: (2022)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
por: Xu, Duoduo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n3ovfi3c1qgb0unohe1o8dgrus